Leslie F Varon

CIK 1207403 · View on SEC EDGAR ↗

Insider

First SEC filing: June 5, 2026 · Latest: June 5, 2026

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.

Insider at

Insider transactions

1 buys (P) 0 sells (S) Net: $99,999 + 53 non-open-market transactions below Avg return of open purchases vs now: 1.3% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

53 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 3, 2026	XRAY	A	22,822	—	—	80,364 Direct	+39.66%	Acquired	(price as of 2026-08-21)
Jan. 9, 2026	XRAY	A	198	—	—	57,541 Direct	+0.35%	Acquired	(price as of 2026-08-21)
Nov. 24, 2025	XRAY	P	9,337	$10.71	$99,999	57,343 Direct	+19.45%	Acquired	1.3% (price as of 2026-08-21)
Oct. 10, 2025	XRAY	A	179	—	—	48,006 Direct	+0.37%	Acquired	(price as of 2026-08-21)
Sept. 16, 2025	HLNE	A	666	—	—	9,658 Direct	+7.41%	Acquired	(price as of 2026-08-21)
July 11, 2025	XRAY	A	139	—	—	47,826 Direct	+0.29%	Acquired	(price as of 2026-08-21)
May 22, 2025	XRAY	A	13,880	—	—	47,687 Direct	+41.06%	Acquired	(price as of 2026-08-21)
April 11, 2025	XRAY	A	87	—	—	33,807 Direct	+0.26%	Acquired	(price as of 2026-08-21)
Jan. 10, 2025	XRAY	A	68	—	—	33,720 Direct	+0.20%	Acquired	(price as of 2026-08-21)
Oct. 11, 2024	XRAY	A	48	—	—	33,651 Direct	+0.14%	Acquired	(price as of 2026-08-21)
July 12, 2024	XRAY	A	51	—	—	33,604 Direct	+0.15%	Acquired	(price as of 2026-08-21)
May 23, 2024	XRAY	A	7,994	—	—	33,552 Direct	+31.28%	Acquired	(price as of 2026-08-21)
April 12, 2024	XRAY	A	36	—	—	25,558 Direct	+0.14%	Acquired	(price as of 2026-08-21)
Jan. 12, 2024	XRAY	A	31	—	—	25,522 Direct	+0.12%	Acquired	(price as of 2026-08-21)
Nov. 10, 2023	LRCX	A	369	—	—	2,834 Direct	+14.97%	Acquired	(price as of 2026-08-21)
Oct. 13, 2023	XRAY	A	59	—	—	25,491 Direct	+0.23%	Acquired	(price as of 2026-08-21)
July 14, 2023	XRAY	A	50	—	—	25,433 Direct	+0.20%	Acquired	(price as of 2026-08-21)
May 25, 2023	XRAY	A	5,419	—	—	25,383 Direct	+27.14%	Acquired	(price as of 2026-08-21)
April 14, 2023	XRAY	A	31	—	—	19,964 Direct	+0.16%	Acquired	(price as of 2026-08-21)
Jan. 13, 2023	XRAY	A	34	—	—	19,932 Direct	+0.17%	Acquired	(price as of 2026-08-21)
Nov. 15, 2022	XRAY	A	6,382	—	—	19,898 Direct	+47.22%	Acquired	(price as of 2026-08-21)
Nov. 11, 2022	LRCX	A	563	—	—	2,465 Direct	+29.60%	Acquired	(price as of 2026-08-21)
Oct. 14, 2022	XRAY	A	11	—	—	13,516 Direct	+0.08%	Acquired	(price as of 2026-08-21)
July 8, 2022	XRAY	A	8	—	—	13,505 Direct	+0.06%	Acquired	(price as of 2026-08-21)
April 8, 2022	XRAY	A	14	—	—	13,497 Direct	+0.10%	Acquired	(price as of 2026-08-21)
Jan. 14, 2022	XRAY	A	11	—	—	13,484 Direct	+0.08%	Acquired	(price as of 2026-08-21)
Nov. 12, 2021	LRCX	A	377	—	—	1,902 Direct	+24.72%	Acquired	(price as of 2026-08-21)
Oct. 8, 2021	XRAY	A	10	$60.01	$600	13,473 Direct	+0.07%	Acquired	-81.9% (price as of 2026-08-21)
July 9, 2021	XRAY	A	9	$64.18	$578	13,463 Direct	+0.07%	Acquired	-83.1% (price as of 2026-08-21)
May 27, 2021	XRAY	A	3,008	—	—	13,454 Direct	+28.80%	Acquired	(price as of 2026-08-21)
April 9, 2021	XRAY	A	12	—	—	10,446 Direct	+0.12%	Acquired	(price as of 2026-08-21)
Jan. 8, 2021	XRAY	A	18	—	—	10,434 Direct	+0.17%	Acquired	(price as of 2026-08-21)
Nov. 6, 2020	LRCX	S	225	$406.45	$91,451	1,525 Direct	-12.86%	Disposed	672.7% (price as of 2026-08-21)
Nov. 6, 2020	LRCX	A	510	—	—	1,750 Direct	+41.13%	Acquired	(price as of 2026-08-21)
Oct. 9, 2020	XRAY	A	16	—	—	10,417 Direct	+0.15%	Acquired	(price as of 2026-08-21)
July 10, 2020	XRAY	A	16	—	—	10,400 Direct	+0.15%	Acquired	(price as of 2026-08-21)
May 21, 2020	XRAY	A	4,766	—	—	10,384 Direct	+84.83%	Acquired	(price as of 2026-08-21)
April 10, 2020	XRAY	A	15	—	—	5,618 Direct	+0.27%	Acquired	(price as of 2026-08-21)
Jan. 10, 2020	XRAY	A	10	—	—	5,603 Direct	+0.18%	Acquired	(price as of 2026-08-21)
Jan. 2, 2020	XRAY	A	552	$56.57	$31,227	552 Direct	—	Acquired	-80.8% (price as of 2026-08-21)
Nov. 8, 2019	LRCX	A	770	—	—	1,240 Direct	+163.83%	Acquired	(price as of 2026-08-21)
Oct. 11, 2019	XRAY	A	11	—	—	5,593 Direct	+0.20%	Acquired	(price as of 2026-08-21)
Aug. 30, 2019	LRCX	A	470	—	—	470 Direct	—	Acquired	(price as of 2026-08-21)
July 12, 2019	XRAY	A	8	—	—	5,583 Direct	+0.14%	Acquired	(price as of 2026-08-21)
May 24, 2019	XRAY	A	3,256	—	—	5,574 Direct	+140.47%	Acquired	(price as of 2026-08-21)
April 12, 2019	XRAY	A	4	—	—	2,318 Direct	+0.17%	Acquired	(price as of 2026-08-21)
Jan. 11, 2019	XRAY	A	5	—	—	2,314 Direct	+0.22%	Acquired	(price as of 2026-08-21)
Oct. 12, 2018	XRAY	A	5	—	—	2,309 Direct	+0.22%	Acquired	(price as of 2026-08-21)
July 13, 2018	XRAY	A	5	—	—	2,303 Direct	+0.22%	Acquired	(price as of 2026-08-21)
May 23, 2018	XRAY	A	8,500	—	—	8,500 Direct	—	Acquired	(price as of 2026-08-21)
May 23, 2018	XRAY	A	1,882	—	—	2,299 Direct	+451.32%	Acquired	(price as of 2026-08-21)
April 13, 2018	XRAY	A	1	—	—	417 Direct	+0.24%	Acquired	(price as of 2026-08-21)
Feb. 13, 2018	XRAY	A	50	—	—	1,800 Direct	+2.86%	Acquired	(price as of 2026-08-21)
Feb. 13, 2018	XRAY	A	416	—	—	416 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 13, 2018	XRAY	A	1,750	—	—	1,750 Direct	—	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Jan. 2, 2020	XRAY	Phantom Stock (Directors' Deferred Compensation) DDC	Common Stock (552)	—	—	552	Acquired
May 23, 2018	XRAY	Stock Option (Right to Buy)	Common Stock (8,500)	$46.50	May 23, 2028	8,500	Acquired
Feb. 13, 2018	XRAY	Stock Option (Right to Buy)	Common Stock (50)	$56.99	Feb. 13, 2028	50	Acquired
Feb. 13, 2018	XRAY	Stock Option (Right to Buy)	Common Stock (1,750)	$56.99	Feb. 13, 2028	1,750	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
May 14, 2019	LRCX	Common Stock [F1]	0	Direct